chronic kidney disease

AstraZeneca's failed cancer drug gets new lease on life thanks to positive kidney disease data
AstraZeneca's failed cancer drug gets new lease on life thanks to positive kidney disease data
Fierce Biotech
AstraZeneca
zibotentan
chronic kidney disease
Flag link:
FDA approves Ardelyx's kidney disease-related drug
FDA approves Ardelyx's kidney disease-related drug
Reuters
Ardelyx
chronic kidney disease
FDA
Xphozah
Flag link:
Novo Nordisk, with coffers filling with cash, buys rival to Bayer's kidney drug Kerendia in $1.3B deal
Novo Nordisk, with coffers filling with cash, buys rival to Bayer's kidney drug Kerendia in $1.3B deal
Fierce Biotech
Novo Nordisk
KBP Biosciences
Bayer
chronic kidney disease
Kerendia
ocedurenone
hypertension
Flag link:
Novo Ends Semaglutide Kidney Study Early Due to Strong Efficacy Signals
Novo Ends Semaglutide Kidney Study Early Due to Strong Efficacy Signals
BioSpace
Novo Nordisk
semaglutide
clinical trials
diabetes
chronic kidney disease
Flag link:
FDA greenlights Jardiance for treating chronic kidney disease
FDA greenlights Jardiance for treating chronic kidney disease
Medical Marketing and Media
Eli Lilly
Boehringer Ingelheim
Medicare
Jardiance
FDA
chronic kidney disease
Flag link:
Jardiance cleared in EU for CKD, challenging Forxiga
Jardiance cleared in EU for CKD, challenging Forxiga
Pharmaphorum
Boehringer Ingelheim
Eli Lilly
Jardiance
Europe
chronic kidney disease
Forxiga
Flag link:
GSK’s daprodustat obtains positive opinion from EMA CHMP
GSK’s daprodustat obtains positive opinion from EMA CHMP
Pharmaceutical Business Review
EMA
Europe
GSK
CHMP
daprodustat
chronic kidney disease
Flag link:
After breakup with Otsuka, Akebia finds new partner for oral anemia drug in Europe
After breakup with Otsuka, Akebia finds new partner for oral anemia drug in Europe
Fierce Pharma
Akebia Therapeutics
Medice Arzneimittel Pütter
Europe
Australia
Vafseo
chronic kidney disease
Flag link:
Genexine's anemia drug matches Roche-CSL product in phase 3, laying groundwork for Asia filings
Genexine's anemia drug matches Roche-CSL product in phase 3, laying groundwork for Asia filings
Fierce Biotech
Genexine
chronic kidney disease
anemia
Roche
CSL Vifor
Mircera
Flag link:
Bayer study finds communication gap in managing chronic kidney disease in patients with type 2 diabetes
Bayer study finds communication gap in managing chronic kidney disease in patients with type 2 diabetes
Medical Marketing and Media
Bayer
diabetes
chronic kidney disease
healthcare providers
physicians
Flag link:
Akebia's Appeal for Anemia in CKD Drug Delayed Again
Akebia's Appeal for Anemia in CKD Drug Delayed Again
BioSpace
Akebia Therapeutics
vadadustat
chronic kidney disease
Flag link:
GSK's oral anemia drug Jesduvroq scores partial FDA nod after 2 rivals suffered rejections
GSK's oral anemia drug Jesduvroq scores partial FDA nod after 2 rivals suffered rejections
Fierce Pharma
GSK
FDA
daprodustat
Jesduvroq
anemia
chronic kidney disease
Flag link:
FDA grants appeal for Ardelyx chronic kidney disease drug after July 2021 rejection
FDA grants appeal for Ardelyx chronic kidney disease drug after July 2021 rejection
Endpoints
Ardelyx
chronic kidney disease
FDA
tenapanor
Flag link:
Kidney Therapeutics to Halt CKD Progression, Make Late-Stage Push Toward NDA
Kidney Therapeutics to Halt CKD Progression, Make Late-Stage Push Toward NDA
BioSpace
Kidney Therapeutics
chronic kidney disease
clinical trials
Flag link:
In surprise turn, FDA adcomm votes in favor of Ardelyx CKD drug despite agency questions
In surprise turn, FDA adcomm votes in favor of Ardelyx CKD drug despite agency questions
Endpoints
Ardelyx
FDA
chronic kidney disease
tenapanor
Flag link:
Akebia Stands by Anemia in CKD Drug in Dispute Resolution Request
Akebia Stands by Anemia in CKD Drug in Dispute Resolution Request
BioSpace
Akebia Therapeutica
FDA
vadadustat
chronic kidney disease
Flag link:
Tricida eyeing sale, cost-cutting options after failing high-stakes CKD wager
Tricida eyeing sale, cost-cutting options after failing high-stakes CKD wager
Endpoints
Tricida
chronic kidney disease
M&A
Flag link:
ASN to Spotlight Debate around Ardelyx's Embattled CKD Drug
ASN to Spotlight Debate around Ardelyx's Embattled CKD Drug
BioSpace
Ardelyx
FDA
tenapanor
chronic kidney disease
Flag link:
Medicare is using one of its biggest hammers to try to fix the dialysis system: how providers are paid
Medicare is using one of its biggest hammers to try to fix the dialysis system: how providers are paid
Stat
dialysis
chronic kidney disease
Medicare
payers
Flag link:
Aria Pharmaceuticals Secures Six Provisional Patents for Pipeline Candidates
Aria Pharmaceuticals Secures Six Provisional Patents for Pipeline Candidates
BioSpace
Aria Pharmaceuticals
patents
lupus
idiopathic pulmonary fibrosis
IPH
chronic kidney disease
Flag link:

Pages